{"entity":{"type":"insider","cik":"0001576081","url":"/insider/0001576081","json_url":"/insider/0001576081.json","name":"CDK ASSOCIATES, L.L.C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":14,"first":"2017-07-20","last":"2020-09-21","span_basis":"filed_date"},"name_variants":[{"name":"CDK ASSOCIATES, L.L.C.","source":"filing","n_filings":14,"first_seen":"2017-07-20","last_seen":"2020-09-21"}],"transactions":[{"id":2786113,"accession":"0000919574-20-005947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-20-005947","line_url":"/filing/0000919574-20-005947#line-2","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"Kovner Bruce; CDK ASSOCIATES, L.L.C.; CAXTON CORP","owner_display_name":"Kovner Bruce","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":13200.0,"total_display":"13,200.00","total_whole":"13,200","shares_owned_after":8060682.0,"shares_owned_after_display":"8,060,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-18","filed_date":"2020-09-21","scope":"insider"},{"id":2786107,"accession":"0000919574-20-005947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-20-005947","line_url":"/filing/0000919574-20-005947#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"Kovner Bruce; CDK ASSOCIATES, L.L.C.; CAXTON CORP","owner_display_name":"Kovner Bruce","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1473377.0,"shares_display":"1,473,377","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":3315098.25,"total_display":"3,315,098.25","total_whole":"3,315,098","shares_owned_after":8054682.0,"shares_owned_after_display":"8,054,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-17","filed_date":"2020-09-21","scope":"insider"},{"id":8308978,"accession":"0000919574-19-007463","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-19-007463","line_url":"/filing/0000919574-19-007463#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"Molecular Templates, Inc.","issuer_ticker":"MTEM","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"CAXTON CORP; CDK ASSOCIATES, L.L.C.; Kovner Bruce; Morenstein Scott D","owner_display_name":"CAXTON CORP","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":468750.0,"shares_display":"468,750","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":3750000.0,"total_display":"3,750,000.00","total_whole":"3,750,000","shares_owned_after":2052991.0,"shares_owned_after_display":"2,052,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-25","scope":"insider"},{"id":6317068,"accession":"0000919574-18-008212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-18-008212","line_url":"/filing/0000919574-18-008212#line-2","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"Kovner Bruce; CDK ASSOCIATES, L.L.C.; CAXTON CORP","owner_display_name":"Kovner Bruce","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18200.0,"shares_display":"18,200","price_per_share":3.9799,"price_display":"3.98","price_state":"stated","total_value":72434.18,"total_display":"72,434.18","total_whole":"72,434","shares_owned_after":6581305.0,"shares_owned_after_display":"6,581,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-27","filed_date":"2018-12-28","scope":"insider"},{"id":6601400,"accession":"0000919574-18-008210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-008210","line_url":"/filing/0000919574-18-008210#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"Molecular Templates, Inc.","issuer_ticker":"MTEM","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"CDK ASSOCIATES, L.L.C.; Kovner Bruce; Morenstein Scott D; CAXTON CORP","owner_display_name":"CDK ASSOCIATES, L.L.C.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":3.45,"price_display":"3.45","price_state":"stated","total_value":86250.0,"total_display":"86,250.00","total_whole":"86,250","shares_owned_after":1584241.0,"shares_owned_after_display":"1,584,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-28","scope":"insider"},{"id":6317063,"accession":"0000919574-18-008212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-008212","line_url":"/filing/0000919574-18-008212#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"Kovner Bruce; CDK ASSOCIATES, L.L.C.; CAXTON CORP","owner_display_name":"Kovner Bruce","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31197.0,"shares_display":"31,197","price_per_share":3.9971,"price_display":"4.00","price_state":"stated","total_value":124697.5287,"total_display":"124,697.53","total_whole":"124,698","shares_owned_after":6563105.0,"shares_owned_after_display":"6,563,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-26","filed_date":"2018-12-28","scope":"insider"},{"id":6817918,"accession":"0000919574-18-008127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-18-008127","line_url":"/filing/0000919574-18-008127#line-2","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"CDK ASSOCIATES, L.L.C.; CAXTON CORP; Kovner Bruce","owner_display_name":"CDK ASSOCIATES, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":90612.0,"shares_display":"90,612","price_per_share":3.9508,"price_display":"3.95","price_state":"stated","total_value":357989.8896,"total_display":"357,989.89","total_whole":"357,990","shares_owned_after":6531908.0,"shares_owned_after_display":"6,531,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-21","filed_date":"2018-12-21","scope":"insider"},{"id":6817913,"accession":"0000919574-18-008127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-008127","line_url":"/filing/0000919574-18-008127#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"CDK ASSOCIATES, L.L.C.; CAXTON CORP; Kovner Bruce","owner_display_name":"CDK ASSOCIATES, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":146467.0,"shares_display":"146,467","price_per_share":3.9967,"price_display":"4.00","price_state":"stated","total_value":585384.6589,"total_display":"585,384.66","total_whole":"585,385","shares_owned_after":6441296.0,"shares_owned_after_display":"6,441,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-20","filed_date":"2018-12-21","scope":"insider"},{"id":6717585,"accession":"0000899243-18-025415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-025415","line_url":"/filing/0000899243-18-025415#line-1","is_derivative":false,"issuer_cik":"0001183765","issuer_name":"Molecular Templates, Inc.","issuer_ticker":"MTEM","issuer_name_source":null,"issuer_url":"/issuer/0001183765","owner_cik":null,"owner_name":"CDK ASSOCIATES, L.L.C.; CAXTON CORP; Morenstein Scott D; Kovner Bruce","owner_display_name":"CDK ASSOCIATES, L.L.C.","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":545454.0,"shares_display":"545,454","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":2999997.0,"total_display":"2,999,997.00","total_whole":"2,999,997","shares_owned_after":1559241.0,"shares_owned_after_display":"1,559,241","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-25","filed_date":"2018-09-27","scope":"insider"},{"id":6039360,"accession":"0000919574-18-005198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-005198","line_url":"/filing/0000919574-18-005198#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"Kovner Bruce; CAXTON CORP; CDK ASSOCIATES, L.L.C.","owner_display_name":"Kovner Bruce","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":360995.0,"shares_display":"360,995","price_per_share":4.9267,"price_display":"4.93","price_state":"stated","total_value":1778514.0665,"total_display":"1,778,514.07","total_whole":"1,778,514","shares_owned_after":6294829.0,"shares_owned_after_display":"6,294,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-08","filed_date":"2018-08-09","scope":"insider"},{"id":6218158,"accession":"0000919574-18-005044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-005044","line_url":"/filing/0000919574-18-005044#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"CDK ASSOCIATES, L.L.C.; CAXTON CORP; Kovner Bruce","owner_display_name":"CDK ASSOCIATES, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":4.6638,"price_display":"4.66","price_state":"stated","total_value":326466.0,"total_display":"326,466.00","total_whole":"326,466","shares_owned_after":5933834.0,"shares_owned_after_display":"5,933,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-30","filed_date":"2018-08-01","scope":"insider"},{"id":6817908,"accession":"0000919574-18-004961","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-18-004961","line_url":"/filing/0000919574-18-004961","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"CAXTON CORP; CDK ASSOCIATES, L.L.C.; Kovner Bruce","owner_display_name":"CAXTON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":209300.0,"shares_display":"209,300","price_per_share":4.726174247491639,"price_display":"4.73","price_state":"stated","total_value":989188.27,"total_display":"989,188.27","total_whole":"989,188","shares_owned_after":5771434.0,"shares_owned_after_display":"5,771,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-27","filed_date":"2018-07-27","scope":"insider","n_lines":2},{"id":6817894,"accession":"0000919574-18-004961","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-18-004961","line_url":"/filing/0000919574-18-004961#line-2","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"CAXTON CORP; CDK ASSOCIATES, L.L.C.; Kovner Bruce","owner_display_name":"CAXTON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39800.0,"shares_display":"39,800","price_per_share":4.9429,"price_display":"4.94","price_state":"stated","total_value":196727.42,"total_display":"196,727.42","total_whole":"196,727","shares_owned_after":5654534.0,"shares_owned_after_display":"5,654,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-26","filed_date":"2018-07-27","scope":"insider"},{"id":6817890,"accession":"0000919574-18-004961","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-004961","line_url":"/filing/0000919574-18-004961#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"CAXTON CORP; CDK ASSOCIATES, L.L.C.; Kovner Bruce","owner_display_name":"CAXTON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":4.9151,"price_display":"4.92","price_state":"stated","total_value":737265.0,"total_display":"737,265.00","total_whole":"737,265","shares_owned_after":5614734.0,"shares_owned_after_display":"5,614,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-24","filed_date":"2018-07-27","scope":"insider"},{"id":6287071,"accession":"0000919574-18-004871","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-18-004871","line_url":"/filing/0000919574-18-004871#line-3","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"Kovner Bruce; CDK ASSOCIATES, L.L.C.; CAXTON CORP","owner_display_name":"Kovner Bruce","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20400.0,"shares_display":"20,400","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":100980.0,"total_display":"100,980.00","total_whole":"100,980","shares_owned_after":5464734.0,"shares_owned_after_display":"5,464,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-23","scope":"insider"},{"id":6287068,"accession":"0000919574-18-004871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-18-004871","line_url":"/filing/0000919574-18-004871#line-2","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"Kovner Bruce; CDK ASSOCIATES, L.L.C.; CAXTON CORP","owner_display_name":"Kovner Bruce","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21100.0,"shares_display":"21,100","price_per_share":4.9666,"price_display":"4.97","price_state":"stated","total_value":104795.26,"total_display":"104,795.26","total_whole":"104,795","shares_owned_after":5444334.0,"shares_owned_after_display":"5,444,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-20","filed_date":"2018-07-23","scope":"insider"},{"id":6287064,"accession":"0000919574-18-004871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-004871","line_url":"/filing/0000919574-18-004871#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"Kovner Bruce; CDK ASSOCIATES, L.L.C.; CAXTON CORP","owner_display_name":"Kovner Bruce","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":4.9819,"price_display":"4.98","price_state":"stated","total_value":69746.6,"total_display":"69,746.60","total_whole":"69,747","shares_owned_after":5423234.0,"shares_owned_after_display":"5,423,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-19","filed_date":"2018-07-23","scope":"insider"},{"id":5956650,"accession":"0000919574-18-004815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-18-004815","line_url":"/filing/0000919574-18-004815#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Strongbridge Biopharma plc","issuer_ticker":"SBBP","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"CAXTON CORP; CDK ASSOCIATES, L.L.C.; Kovner Bruce","owner_display_name":"CAXTON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11200.0,"shares_display":"11,200","price_per_share":4.9669,"price_display":"4.97","price_state":"stated","total_value":55629.28,"total_display":"55,629.28","total_whole":"55,629","shares_owned_after":5409234.0,"shares_owned_after_display":"5,409,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-16","filed_date":"2018-07-18","scope":"insider"},{"id":9208391,"accession":"0000919574-17-005551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-17-005551","line_url":"/filing/0000919574-17-005551#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"CAXTON CORP; CDK ASSOCIATES, L.L.C.; Kovner Bruce","owner_display_name":"CAXTON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":215000.0,"shares_display":"215,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3225000.0,"total_display":"3,225,000.00","total_whole":"3,225,000","shares_owned_after":763755.0,"shares_owned_after_display":"763,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider"},{"id":9208390,"accession":"0000919574-17-005547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-17-005547","line_url":"/filing/0000919574-17-005547#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"CAXTON CORP; CDK ASSOCIATES, L.L.C.; Kovner Bruce","owner_display_name":"CAXTON CORP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":215000.0,"shares_display":"215,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3225000.0,"total_display":"3,225,000.00","total_whole":"3,225,000","shares_owned_after":763755.0,"shares_owned_after_display":"763,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider"},{"id":4257652,"accession":"0000919574-17-005533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-17-005533","line_url":"/filing/0000919574-17-005533#line-1","is_derivative":false,"issuer_cik":"0001325713","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001325713","owner_cik":null,"owner_name":"Kovner Bruce; CAXTON CORP; CDK ASSOCIATES, L.L.C.","owner_display_name":"Kovner Bruce","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":215000.0,"shares_display":"215,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3225000.0,"total_display":"3,225,000.00","total_whole":"3,225,000","shares_owned_after":215000.0,"shares_owned_after_display":"215,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001634432","name":"Strongbridge Biopharma plc","url":"/issuer/0001634432","role":"Ten percent owner","n_filings":8,"first_seen":"2018-07-18","last_seen":"2020-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001183765","name":"Molecular Templates, Inc.","url":"/issuer/0001183765","role":"Director","n_filings":3,"first_seen":"2018-09-27","last_seen":"2019-11-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001479419","name":"Kala Pharmaceuticals, Inc.","url":"/issuer/0001479419","role":"Ten percent owner","n_filings":3,"first_seen":"2017-07-20","last_seen":"2017-07-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001576081","retrieved_at":"2026-08-24T06:36:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}